As the corporate venture capital arm of Fresenius Medical Care, the firm strategically invests in startups developing novel products and therapies within the renal care and adjacent therapeutic areas. This includes medical devices, pharmaceuticals, digital health, and care delivery models that can complement the parent company's global dialysis and kidney care business.